Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04444518 · ClinicalTrials.gov registry record · NA
Increasing Influenza and Tdap Vaccination of Pregnant Women
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 12,760
- Enrollment target
NCT04444518: Completed NA study, sponsored by University of Rochester.
NCT04444518 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 12,760 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (809% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04444518, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,760 participants
- Enrollment target
Study Summary
Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.
Primary Outcome
Influenza vaccination rate during pregnancy. Vaccination status will be obtained from patient electronic health records.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL VAX-MOM Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,760 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT04444518 record still lists
NCT04444518 is an interventional study that assigns participants to a tested intervention. Its 12,760 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (809% higher).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04444518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04444518 about?
NCT04444518 is a clinical study titled "Increasing Influenza and Tdap Vaccination of Pregnant Women". Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women ar...
What is the current status of trial NCT04444518?
This trial is currently completed. It is a NA study. The enrollment target is 12,760 participants. The study started on 2019-07-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04444518?
The interventions under investigation include: Standard of Care (BEHAVIORAL), VAX-MOM Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04444518?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04444518's enrollment target sits among peer trials
12,760 13th of 2000 higher than 1,988 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07037433 · 12,800 participants · Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- NCT03586895 · 12,838 participants · NA
e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide
- NCT07028398 · 12,990 participants · NA
CMSL Ambulatory Sensitive Condition Nudge Study 2
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI